Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes
2004 StandoutNobel
Development and Implementation of a Miniaturized High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Identify Small Molecule Inhibitors of Polo-Like Kinase 1
2007
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Hallmarks of Cancer: The Next Generation
2011 Standout
Functional Properties of a Monoclonal Antibody Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase
2002
Intracellular Delivery System for Antibody–Peptide Drug Conjugates
2015 StandoutNobel
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
The tumor microenvironment is a dominant force in multidrug resistance
2012
De novo protein design. I. in search of stability and specificity
1999 StandoutNobel
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
TGF-β1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation
2005
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Oncogenes as Novel Targets for Cancer Therapy (Part IV)
2005
Delivery materials for siRNA therapeutics
2013 Standout
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
The biology and function of fibroblasts in cancer
2016 Standout
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival
2002
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
2004 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Models, mechanisms and clinical evidence for cancer dormancy
2007
Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy
2016
Pseudomonas exotoxin A: From virulence factor to anti-cancer agent
2008
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Non-viral vectors for gene-based therapy
2014 Standout
Dormancy of Solitary Metastatic Cells
2006
p21 in cancer: intricate networks and multiple activities
2009 Standout
Current progress of siRNA/shRNA therapeutics in clinical trials
2011
Protein toxins: intracellular trafficking for targeted therapy
2005
Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma
2006
How were new medicines discovered?
2011 Standout
Novel Therapeutic Strategies to Selectively Kill Cancer Cells
1998
Emerging Biological Principles of Metastasis
2017 Standout
PI3K/Akt signalling pathway and cancer
2003 Standout
Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily
2000
The cancer stem cell: premises, promises and challenges
2011 Standout
Microenvironmental regulation of metastasis
2008 Standout
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Clonal evolution in cancer
2012 StandoutNature
PEGylation, successful approach to drug delivery
2005 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
2001
Targeting polo-like kinase 1 for cancer therapy
2006
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs
1999
Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting
2001 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
A novel form of constitutively active farnesylated Akt1 prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis
2002
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
2017
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
1999 Standout
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
Bispecific Antibodies as Novel Bioconjugates
1998
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A
2016 StandoutNobel
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Immunogenicity of therapeutic recombinant immunotoxins
2016
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication
2007 StandoutNobel
Mechanisms of Cancer Drug Resistance
2002 Standout
Synthesis and Biological Evaluation of N-Heterocyclic Indolyl Glyoxylamides as Orally Active Anticancer Agents
2003
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
2001
Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells
2003 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Poly(ethylene glycol)-Conjugated Anti-EGF Receptor Antibody C225 with Radiometal Chelator Attached to the Termini of Polymer Chains
2001
Efficient and Rapid Template-Directed Nucleic Acid Copying Using 2′-Amino-2′,3′-dideoxyribonucleoside−5′-Phosphorimidazolide Monomers
2009 StandoutNobel
Immunotoxins for targeted cancer therapy
1998
5-Alkynyl-2′-deoxyuridines, containing bulky aryl groups: evaluation of structure–anti-HSV-1 activity relationship
2005
Multiple event activation of a generic prodrug trigger by antibody catalysis
1999 StandoutNobel
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Near-infrared fluorophores for biomedical imaging
2017 Standout
Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy.
2001
Pyrrolo-dC and pyrrolo-C: fluorescent analogs of cytidine and 2′-deoxycytidine for the study of oligonucleotides
2004
Works of Mathias Schmidt being referenced
Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-α
1998
Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2
2003
EGF receptor and p185erbB‐2‐specific single‐chain antibody toxins differ in their cell‐killing activity on tumor cells expressing both receptor proteins
1995
A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor
1996
Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects
1997
Overexpression of polo-like kinase 1 is a common and early event in pancreatic cancer
2005
Differential Roles of p21Waf1 and p27Kip1in Modulating Chemosensitivity and Their Possible Application in Drug Discovery Studies
2001
Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor
1997
Synthesis of a potential antiviral compound: 5-bromoethynyl-2′-deoxyuridine
1994
Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.
2000
Steric fixation of bromovinyluracil: Synthesis of furo[2,3‐d]pyrimidine nucleosides
1995